Under the leadership of Dr. Melanie Ott, Gladstone Institute of Virology will study COVID-19 and study novel therapies against future infectious diseases. Researchers will focus on the way viruses interact with human host cells to cause disease and how to intervene in that process.

The other facility, which is a partnership between Gladstone and the University of California, San Francisco (UCSF), is the Gladstone-UCSF Institute of Genomic Immunology. Led by Dr. Alexander Marson, this facility will work to better understand the genetic control of human immune cells and develop novel cell-based immunotherapies.

Genomic tools help researchers understand how SARS-CoV-2 is evolving
A new study has identified nearly 200 recurrent genetic mutations in the SARS-CoV-2 virus, according to research published as a preproof in Infection,...

Scientists explore varying immune responses in COVID-19 patients
A new study aims to further classify the immune response of COVID-19 patients with the goal of understanding the pathogenesis of the disease and accelerating...

Bringing order to the viral multiverse
A new taxonomic classification system for viruses has been proposed by the International Committee on Taxonomy of Viruses, the group that oversees the...

AI engine analyzes over 50,000 novel coronavirus papers
Clinical artificial intelligence (AI) software developer Mendel said it has developed an AI-based search engine that can analyze more than 50,000 novel...

Gladstone Institutes launches COVID-19 fund
Gladstone Institutes is seeking donations to mobilize resources and start research projects to help fight the COVID-19 pandemic.